Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
16
CUE Quote, Financials, Valuation and Earnings
Last price:
$0.63
Seasonality move
:
-28.74%
Day range:
$0.63 - $0.67
52-week range:
$0.45 - $1.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.99x
P/B ratio:
7.31x
Volume:
114.2K
Avg. volume:
151.9K
1-year change:
-59.87%
Market cap:
$48.1M
Revenue:
$9.3M
EPS (TTM):
-$0.67
Earnings Data
Next earnings date for CUE
Aug 19
2025
Most recent earnings per share
-$0.17
Missed by $0.02
(May 12/2025)
Consensus Estimate
-$0.15
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CUE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/19/2025 | Q2 | $2M | -- | -- | -$0.13 | -- |
| 05/12/2025 | Q1 | $1.3M | $421K | -$0.17 | -$0.15 | -$0.02 |
| 03/31/2025 | Q4 | $1.7M | $1.6M | -$0.13 | -$0.15 | $0.02 |
| 11/14/2024 | Q3 | $1.5M | $3.3M | -$0.17 | -$0.19 | $0.02 |
| 08/19/2024 | Q2 | $1.3M | $2.7M | -$0.20 | -$0.28 | $0.08 |
| 05/09/2024 | Q1 | $1.2M | $1.7M | -$0.25 | -$0.29 | $0.04 |
| 03/21/2024 | Q4 | $1.6M | $1.8M | -$0.29 | -$0.28 | -$0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.24 | -$0.34 | $0.10 |
| 08/09/2023 | Q2 | -- | -- | -$0.29 | -$0.31 | $0.02 |
| 05/09/2023 | Q1 | -- | -- | -$0.29 | -$0.29 | -- |
| 03/21/2023 | Q4 | -- | -- | -$0.38 | -$0.31 | -$0.07 |
| 11/14/2022 | Q3 | -- | -- | -$0.31 | -$0.38 | $0.07 |
| 08/04/2022 | Q2 | -- | -- | -$0.37 | -$0.40 | $0.03 |
| 05/10/2022 | Q1 | -- | -- | -$0.44 | -$0.42 | -$0.02 |
| 03/16/2022 | Q4 | -- | -- | -$0.25 | -$0.41 | $0.16 |
| 11/09/2021 | Q3 | -- | -- | -$0.41 | -$0.37 | -$0.04 |
| 08/17/2021 | Q2 | -- | -- | -$0.33 | -$0.40 | $0.07 |
| 05/17/2021 | Q1 | -- | -- | -$0.41 | -$0.36 | -$0.06 |
| 03/16/2021 | Q4 | -- | -- | -$0.36 | -$0.35 | -$0.01 |
| 11/17/2020 | Q3 | -- | -- | -$0.34 | -$0.38 | $0.04 |
| 08/31/2020 | Q2 | -- | -- | -$0.38 | -$0.43 | $0.05 |
| 05/19/2020 | Q1 | -- | -- | -$0.48 | -$0.37 | -$0.11 |
| 03/17/2020 | Q4 | -- | -- | -$0.37 | -$0.44 | $0.07 |
| 11/12/2019 | Q3 | -- | -- | -$0.31 | -$0.44 | $0.13 |
| 08/08/2019 | Q2 | -- | -- | -$0.46 | -$0.56 | $0.10 |
| 05/08/2019 | Q1 | -- | -- | -$0.54 | -$0.40 | -$0.14 |
| 03/14/2019 | Q4 | -- | -- | -$0.58 | -$0.40 | -$0.18 |
| 11/13/2018 | Q3 | -- | -- | -$0.62 | -- | -- |
| 08/13/2018 | Q2 | -- | -- | -$0.36 | -- | -- |
| 05/14/2018 | Q1 | -- | -- | -$0.37 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.51 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.21 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.16 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.14 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.10 | -- | -- |
Cue Biopharma Earnings Questions
-
How Much did Cue Biopharma Generate in Revenue Last Quarter?
Cue Biopharma reported $421K worth of top line sales in its most recent quarter.
-
Did Cue Biopharma Beat Earnings Last Quarter?
Cue Biopharma announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Cue Biopharma Profitable?
Cue Biopharma reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cue Biopharma EPS Next Year?
Cue Biopharma's earnings are forecast to decrease from -$0.72 per share to -$0.55 per share next year representing a decrease of -23.61%.
-
When is Cue Biopharma's Earnings Date?
Cue Biopharma's next earnings date is August 19, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
